Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

AcelRx Pharmaceuticals Inc (NASDAQ:ACRX)

3.69
Delayed Data
As of 1:04pm ET
 -0.21 / -5.38%
Today’s Change
2.40
Today|||52-Week Range
5.88
-4.16%
Year-to-Date
AcelRx (ACRX) Initiates Phase III IAP312 Study on Zalviso
Sep 28 / Zacks.com - Paid Partner Content
Company News for September 16, 2016
Sep 16 / Zacks.com - Paid Partner Content